All cancer types, Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 1
This trial looked at vandetanib and selumetinib for people who have , including non small cell lung cancer. A solid tumour is any cancer apart from leukaemia or lymphoma.
The trial was supported by Cancer Research UK. It was open for people to join between 2011 and 2017. The team reported the results in 2021.
Recruitment start: 16 December 2011
Recruitment end: 13 October 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Denis Talbot
AstraZeneca
Cancer Research UK (Centre for Drug Development) - trial sponsor, regulatory@cancer.org.uk
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/11/001.
There is more information about this trial (NCT01586624) on the clinicaltrials.gov website:
Last reviewed: 2 August 2022
CRUK internal database number: 6787
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
